Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 19 studies | 51% ± 15% | |
| brain | 19 studies | 41% ± 16% | |
| peripheral blood | 18 studies | 41% ± 12% | |
| intestine | 12 studies | 40% ± 16% | |
| eye | 12 studies | 52% ± 21% | |
| kidney | 9 studies | 44% ± 9% | |
| liver | 7 studies | 46% ± 19% | |
| bone marrow | 6 studies | 34% ± 9% | |
| pancreas | 5 studies | 64% ± 21% | |
| uterus | 5 studies | 59% ± 16% | |
| prostate | 5 studies | 33% ± 9% | |
| lymph node | 5 studies | 45% ± 6% | |
| placenta | 4 studies | 49% ± 16% | |
| breast | 4 studies | 49% ± 8% | |
| adipose | 4 studies | 31% ± 11% | |
| heart | 3 studies | 31% ± 5% | |
| adrenal gland | 3 studies | 41% ± 4% | |
| skin | 3 studies | 38% ± 7% | |
| thymus | 3 studies | 48% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 11682.50 | 2642 / 2642 | 100% | 89.79 | 705 / 705 |
| breast | 100% | 8108.52 | 459 / 459 | 100% | 84.93 | 1118 / 1118 |
| esophagus | 100% | 6600.64 | 1445 / 1445 | 100% | 94.62 | 183 / 183 |
| lung | 100% | 7889.40 | 578 / 578 | 100% | 83.57 | 1155 / 1155 |
| ovary | 100% | 7283.28 | 180 / 180 | 100% | 67.84 | 430 / 430 |
| pancreas | 100% | 6293.90 | 328 / 328 | 100% | 57.50 | 178 / 178 |
| prostate | 100% | 7997.28 | 245 / 245 | 100% | 96.86 | 502 / 502 |
| thymus | 100% | 10603.17 | 653 / 653 | 100% | 98.44 | 605 / 605 |
| uterus | 100% | 7902.07 | 170 / 170 | 100% | 58.13 | 459 / 459 |
| liver | 100% | 6488.26 | 226 / 226 | 100% | 45.51 | 405 / 406 |
| bladder | 100% | 7619.62 | 21 / 21 | 99% | 48.02 | 500 / 504 |
| adrenal gland | 100% | 8605.04 | 258 / 258 | 99% | 63.18 | 228 / 230 |
| kidney | 100% | 6207.57 | 89 / 89 | 99% | 77.82 | 893 / 901 |
| stomach | 100% | 7079.26 | 359 / 359 | 98% | 61.78 | 280 / 286 |
| intestine | 100% | 7566.58 | 966 / 966 | 98% | 53.98 | 515 / 527 |
| skin | 100% | 5369.47 | 1800 / 1809 | 92% | 46.76 | 433 / 472 |
| adipose | 100% | 8942.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 8068.74 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 54.49 | 29 / 29 |
| spleen | 100% | 7177.23 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 23.98 | 1 / 1 |
| muscle | 99% | 3505.99 | 794 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 4073.76 | 847 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 52.91 | 44 / 45 |
| peripheral blood | 95% | 5455.65 | 884 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 55% | 14.22 | 44 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006620 | Biological process | post-translational protein targeting to endoplasmic reticulum membrane |
| GO_0006613 | Biological process | cotranslational protein targeting to membrane |
| GO_0031204 | Biological process | post-translational protein targeting to membrane, translocation |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005791 | Cellular component | rough endoplasmic reticulum |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0038023 | Molecular function | signaling receptor activity |
| Gene name | SEC62 |
| Protein name | Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1) SEC62 homolog, preprotein translocation factor Translocation protein SEC62 |
| Synonyms | TLOC1 |
| Description | FUNCTION: Mediates post-translational transport of precursor polypeptides across endoplasmic reticulum (ER). Proposed to act as a targeting receptor for small presecretory proteins containing short and apolar signal peptides. Targets and properly positions newly synthesized presecretory proteins into the SEC61 channel-forming translocon complex, triggering channel opening for polypeptide translocation to the ER lumen. . |
| Accessions | ENST00000469515.6 F8WDG8 F8WF48 ENST00000337002.9 F8WCJ7 Q99442 A0JLN5 ENST00000460513.5 Q3KR08 ENST00000480708.5 ENST00000487736.5 |